Finance

Lists
Why is 6472 down 9.97%?
Dive Deeper
6472:TPE
Bora Pharmaceuticals Co Ltd
NT$280.00
-9.97%
(-31.00) 1D
Nov 20, 1:30:13 PM GMT+8  ·   TWD
All symbols
SymbolPriceChange% Change
Generating top insights for 6472...
Open
NT$309.50
High
NT$309.50
Low
NT$280.00
Mkt. cap
35.85B
Avg. vol.
814.06K
Volume
1.66M
P/E ratio
23.61
52-wk high
NT$633.00
52-wk low
NT$280.00
EPS
NT$11.86
No. of employees
36
Open
NT$309.50
High
NT$309.50
Low
NT$280.00
Mkt. cap
35.85B
Avg. vol.
814.06K
Volume
1.66M
P/E ratio
23.61
52-wk high
NT$633.00
52-wk low
NT$280.00
EPS
NT$11.86
No. of employees
36
News stories
From web sources and news partners
About Bora Pharmaceuticals Co Ltd
CEOBobby Sheng
Employees36
Founded2007
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Last report
Nov 13, 2026
Fiscal period
Q3 2026
NT$4.66 / NT$5.23
-10.96%miss
Revenue / Est. (TWD)
6.45B / 6.28B
+2.79%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in TWD
Loading Previous Earnings...
Revenue
Net income
All values in TWD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
4.86B
4.00B
5.89B
6.45B
Cost of goods sold
3.09B
2.56B
3.46B
3.92B
Cost of revenue
3.09B
2.56B
3.46B
3.92B
Research and development expenses
181.25M
167.93M
190.74M
182.11M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.03B
866.09M
1.25B
1.26B
Operating expense
1.22B
1.04B
1.44B
1.44B
Total operating expenses
4.30B
3.59B
4.90B
5.36B
Operating income
556.34M
407.24M
986.64M
1.09B
Other non operating income
15.19M
24.01M
-15.28M
14.83M
EBT including unusual items
809.67M
221.15M
813.10M
802.18M
EBT excluding unusual items
375.02M
222.24M
788.94M
802.18M
Income tax expense
381.93M
174.25M
205.59M
150.36M
Effective tax rate
47.17%
78.79%
25.28%
18.74%
Other operating expenses
1.24M
1.37M
-
-
Net income
331.76M
25.84M
555.76M
611.94M
Net profit margin
6.83%
0.65%
9.44%
9.48%
Earnings per share
2.78
0.20
4.24
4.66
Interest and investment income
10.49M
6.25M
11.16M
-
Interest expense
-122.01M
-113.73M
-124.33M
-187.91M
Net interest expenses
-111.52M
-107.48M
-113.17M
-187.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
784.95M
634.54M
1.27B
1.60B
Gain or loss from assets sale
1.32M
63.00K
2.00K
2.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps